Related Experiment Video
Updated: May 23, 2026

05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
On optimal gene-based analysis of genome scans
1Virginia Commonwealth University, Richmond, Virginia 23219, USA. sabacanu@vcu.edu
Genetic Epidemiology
|April 18, 2012
Summary
Gene-wide analysis methods boost power for genetic studies with multiple causal variants. A two-step approach using Simes and adaptive sum (aSUM) or VEGAS offers scalable and powerful genome-wide association analysis.
Area of Science:
- Genetics
- Statistical Genetics
- Bioinformatics
Background:
- Univariate marker analysis has limited power with multiple causal variants per gene.
- Gene-wide statistics combining variant effects are hypothesized to increase power.
- The performance and scalability of gene-wide methods for whole-genome scans, especially with sequence data, remain unclear.
Purpose of the Study:
- To assess the performance and scalability of various gene-based methods for genome-wide association studies (GWAS).
- To compare commonly used (VEGAS, GATES), less common (Simes, aSUM, kernel), and novel proposed methods.
Main Methods:
- Realistic simulations were employed to evaluate method performance.
- Methods assessed include VEGAS, GATES, Simes, adaptive sum (aSUM), kernel methods, and a proposed combined univariate/multivariate statistic.
- Scalability was considered for large-scale analyses like genome-wide sequence data.
Main Results:
- Simes demonstrated high speed and good power for single causal variant models.
- The aSUM method showed strong power for multiple causal variants, particularly with shorter genes.
- The proposed statistic exhibited good power across all tested causal models.
- A two-step strategy (Simes followed by aSUM or VEGAS) is recommended for sequencing data analysis.
Conclusions:
- A two-step genome scan analysis is recommended for sequencing studies, using Simes for initial screening and computationally intensive methods for refinement.
- The proposed method provides a viable alternative, offering good power with modest trade-offs.
- Method selection should consider gene length and the number of causal variants for optimal power in genome-wide association studies.
Related Concept Videos
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Evolutionary Relationships through Genome Comparisons
Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...
Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

